Winning the war: Science parkour

Science Translational Medicine

Volumn 4, Issue 127, 2012, Pages

  Vogelstein, Bert ^a,b,c   Kinzler, Kenneth W ^a,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Department of Oncology and Pathology ^*  (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IPILIMUMAB; PROSTATE SPECIFIC ANTIGEN; TRASTUZUMAB; TUMOR MARKER; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CANCER PREVENTION; CANCER RESEARCH; CANCER RESISTANCE; CANCER SCREENING; DIAGNOSTIC VALUE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG RESEARCH; EARLY DIAGNOSIS; EDITORIAL; FUNCTIONAL GENOMICS; FUNCTIONAL PROTEOMICS; HEALTH CARE PLANNING; HUMAN; KIDNEY CARCINOMA; MEDICAL LITERATURE; MELANOMA; METASTASIS; MOLECULARLY TARGETED THERAPY; NONHUMAN; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROSTATE CANCER; TRANSLATIONAL RESEARCH; IMMUNOTHERAPY; MEDICAL RESEARCH; METABOLISM; NEOPLASM;

ANTINEOPLASTIC AGENTS; BIOMEDICAL RESEARCH; HUMANS; IMMUNOTHERAPY; MOLECULAR TARGETED THERAPY; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84859125342     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3004019     Document Type: Editorial

References (0)